These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 16177328

  • 21. Minor nucleotide substitutions in the omp31 gene of Brucella ovis result in antigenic differences in the major outer membrane protein that it encodes compared to those of the other Brucella species.
    Vizcaíno N, Kittelberger R, Cloeckaert A, Marín CM, Fernández-Lago L.
    Infect Immun; 2001 Nov; 69(11):7020-8. PubMed ID: 11598077
    [Abstract] [Full Text] [Related]

  • 22. Simultaneous immunization of mice with Omp31 and TF provides protection against Brucella melitensis infection.
    Ghasemi A, Jeddi-Tehrani M, Mautner J, Salari MH, Zarnani AH.
    Vaccine; 2015 Oct 13; 33(42):5532-5538. PubMed ID: 26384448
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of humoral and cellular immune responses to BP26 and OMP31 epitopes in the attenuated Brucella melitensis vaccinated sheep.
    Wang W, Wu J, Qiao J, Weng Y, Zhang H, Liao Q, Qiu J, Chen C, Allain JP, Li C.
    Vaccine; 2014 Feb 07; 32(7):825-33. PubMed ID: 24370708
    [Abstract] [Full Text] [Related]

  • 24. Induction of specific cell-mediated immune responses and protection in BALB/c mice by vaccination with outer membrane vesicles from a Brucella melitensis human isolate.
    Bagheri Nejad R, Yahyaraeyat R, Es-Haghi A, Nayeri Fasaei B, Zahraei Salehi T.
    APMIS; 2019 Dec 07; 127(12):797-804. PubMed ID: 31514254
    [Abstract] [Full Text] [Related]

  • 25. Brucella melitensis omp31 Mutant Is Attenuated and Confers Protection Against Virulent Brucella melitensis Challenge in BALB/c Mice.
    Verdiguel-Fernández L, Oropeza-Navarro R, Ortiz A, Robles-Pesina MG, Ramírez-Lezama J, Castañeda-Ramírez A, Verdugo-Rodríguez A.
    J Microbiol Biotechnol; 2020 Apr 28; 30(4):497-504. PubMed ID: 31986561
    [Abstract] [Full Text] [Related]

  • 26. Recombinant Lactococcus Lactis Displaying Omp31 Antigen of Brucella melitensis Can Induce an Immunogenic Response in BALB/c Mice.
    Shirdast H, Ebrahimzadeh F, Taromchi AH, Mortazavi Y, Esmaeilzadeh A, Sekhavati MH, Nedaei K, Mirabzadeh E.
    Probiotics Antimicrob Proteins; 2021 Feb 28; 13(1):80-89. PubMed ID: 32661939
    [Abstract] [Full Text] [Related]

  • 27. Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model.
    Paul S, Peddayelachagiri BV, Nagaraj S, Kingston JJ, Batra HV.
    Mol Immunol; 2018 Jul 28; 99():9-18. PubMed ID: 29649688
    [Abstract] [Full Text] [Related]

  • 28. Evaluation in mice of Brucella ovis attenuated mutants for use as live vaccines against B. ovis infection.
    Sancho P, Tejedor C, Sidhu-Muñoz RS, Fernández-Lago L, Vizcaíno N.
    Vet Res; 2014 Jun 04; 45(1):61. PubMed ID: 24898325
    [Abstract] [Full Text] [Related]

  • 29. A combined DNA vaccine encoding BCSP31, SOD, and L7/L12 confers high protection against Brucella abortus 2308 by inducing specific CTL responses.
    Yu DH, Hu XD, Cai H.
    DNA Cell Biol; 2007 Jun 04; 26(6):435-43. PubMed ID: 17570767
    [Abstract] [Full Text] [Related]

  • 30. The candidate vaccine strain Brucella ovis ∆abcBA is protective against Brucella melitensis infection in mice.
    Costa LF, Cabello AL, Batista DFA, Chaki SP, de Figueiredo P, da Paixão TA, Rice-Ficht AC, Ficht TA, Santos RL.
    Microbiol Immunol; 2020 Nov 04; 64(11):730-736. PubMed ID: 32965738
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of immunogenicity and protective activity in BALB/c mice of the 25-kDa major outer-membrane protein of Brucella melitensis (Omp25) expressed in Escherichia coli.
    Bowden RA, Cloeckaert A, Zygmunt MS, Dubray G.
    J Med Microbiol; 1998 Jan 04; 47(1):39-48. PubMed ID: 9449948
    [Abstract] [Full Text] [Related]

  • 32. A comparison between adjuvant and delivering functions of calcium phosphate, aluminum hydroxide and chitosan nanoparticles, using a model protein of Brucella melitensis Omp31.
    Abkar M, Alamian S, Sattarahmady N.
    Immunol Lett; 2019 Mar 04; 207():28-35. PubMed ID: 30707922
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
    Adone R, Francia M, Ciuchini F.
    Vaccine; 2008 Sep 08; 26(38):4913-7. PubMed ID: 18675869
    [Abstract] [Full Text] [Related]

  • 34. Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model.
    Tadepalli G, Singh AK, Balakrishna K, Murali HS, Batra HV.
    Mol Immunol; 2016 Mar 08; 71():34-41. PubMed ID: 26826463
    [Abstract] [Full Text] [Related]

  • 35. Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus 544.
    Goel D, Rajendran V, Ghosh PC, Bhatnagar R.
    Vaccine; 2013 Feb 06; 31(8):1231-7. PubMed ID: 23273966
    [Abstract] [Full Text] [Related]

  • 36. Nasal vaccination stimulates CD8(+) T cells for potent protection against mucosal Brucella melitensis challenge.
    Clapp B, Yang X, Thornburg T, Walters N, Pascual DW.
    Immunol Cell Biol; 2016 May 06; 94(5):496-508. PubMed ID: 26752510
    [Abstract] [Full Text] [Related]

  • 37. Invasive Escherichia coli vaccines expressing Brucella melitensis outer membrane proteins 31 or 16 or periplasmic protein BP26 confer protection in mice challenged with B. melitensis.
    Gupta VK, Radhakrishnan G, Harms J, Splitter G.
    Vaccine; 2012 Jun 08; 30(27):4017-22. PubMed ID: 22546330
    [Abstract] [Full Text] [Related]

  • 38. Efficacy of bp26 and bp26/omp31 B. melitensis Rev.1 deletion mutants against Brucella ovis in rams.
    Grilló MJ, Marín CM, Barberán M, de Miguel MJ, Laroucau K, Jacques I, Blasco JM.
    Vaccine; 2009 Jan 07; 27(2):187-91. PubMed ID: 19007836
    [Abstract] [Full Text] [Related]

  • 39. The 16MΔvjbR as an ideal live attenuated vaccine candidate for differentiation between Brucella vaccination and infection.
    Wang Y, Bai Y, Qu Q, Xu J, Chen Y, Zhong Z, Qiu Y, Wang T, Du X, Wang Z, Yu S, Fu S, Yuan J, Zhen Q, Yu Y, Chen Z, Huang L.
    Vet Microbiol; 2011 Aug 05; 151(3-4):354-62. PubMed ID: 21530111
    [Abstract] [Full Text] [Related]

  • 40. Protective and therapeutic efficacy study of divalent fusion protein rL7/L12-Omp25 against B. abortus 544 in presence of IFNγ.
    Paul S, Peddayelachagiri BV, Nagaraj S, Konduru B, Batra HV.
    Appl Microbiol Biotechnol; 2018 Oct 05; 102(20):8895-8907. PubMed ID: 30136204
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.